Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Chemotherapy, Adjuvant"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 21-40 z 4146
Tytuł:
Prognostic factors and benefit populations of ovarian function suppression in premenopausal HR+/HER2+ early-stage breast cancer patients who received trastuzumab: Evidence from a real-world study with long-term follow-up.
Autorzy:
Ju J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Gao SL; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), The VIPII Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital and Institute, Beijing, China.
Wang JY; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Sang D; Department of Medical Oncology, Beijing Sanhuan Cancer Hospital, Beijing, China.
Kang YK; Department of Medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Wang X; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yue J; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shuai Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qi YX; Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shi Jiazhuang, China.
Yuan P; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (6), pp. 439-447. Date of Electronic Publication: 2024 Jan 07.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Humans ; Adult ; Female ; Trastuzumab/pharmacology ; Trastuzumab/therapeutic use ; Follow-Up Studies ; Prognosis ; Toremifene/therapeutic use ; Retrospective Studies ; Tamoxifen/therapeutic use ; Disease-Free Survival ; Chemotherapy, Adjuvant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transfer learning of pre-treatment quantitative ultrasound multi-parametric images for the prediction of breast cancer response to neoadjuvant chemotherapy.
Autorzy:
Falou O; Department of Physics, Toronto Metropolitan University, Toronto, ON, Canada. .; Institute for Biomedical Engineering, Science and Technology (iBEST), Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada. .
Sannachi L; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Physical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Haque M; Department of Physics, Toronto Metropolitan University, Toronto, ON, Canada.
Czarnota GJ; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Physical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Kolios MC; Department of Physics, Toronto Metropolitan University, Toronto, ON, Canada.; Institute for Biomedical Engineering, Science and Technology (iBEST), Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 29; Vol. 14 (1), pp. 2340. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Humans ; Female ; Neoadjuvant Therapy ; Ultrasonography/methods ; Chemotherapy, Adjuvant ; Machine Learning
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components.
Autorzy:
Li R; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.
Qiu J; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.
Li Z; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.
Li H; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.
Tang Z; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.
Yu W; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.
Tian H; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.
Sun Z; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2024 Jan 25; Vol. 22 (1), pp. 32. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/surgery
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/surgery
Humans ; Prognosis ; Retrospective Studies ; Neoplasm Staging ; Disease-Free Survival ; Chemotherapy, Adjuvant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of adjuvant chemotherapy on the oncological outcome of rectal cancer patients with pathological complete response.
Autorzy:
Yang J; Department of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Deng Q; Department of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Cheng Y; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Fu Z; Department of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.
Wu X; Department of General Surgery, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2024 Jan 25; Vol. 22 (1), pp. 31. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Chemoradiotherapy*
Rectal Neoplasms*/pathology
Humans ; Retrospective Studies ; Neoplasm Staging ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Neoadjuvant Therapy ; Pathologic Complete Response ; Treatment Outcome ; Chemoradiotherapy, Adjuvant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Impact of Chemotherapy on Cardiovascular Mortality across Breast Cancer Subtypes.
Autorzy:
Ngô TM; Gyula Petrányi Doctoral School of Clinical Immunology and Allergology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.; Medical Imaging Clinic, Clinical Centre, University of Debrecen, H-4032 Debrecen, Hungary.
Lê ÁN; Faculty of Health Sciences, University of Debrecen, H-4032 Debrecen, Hungary.
Đinh DPH; Faculty of Health Sciences, University of Debrecen, H-4032 Debrecen, Hungary.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jan 24; Vol. 31 (2), pp. 649-659. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Triple Negative Breast Neoplasms*/drug therapy
Cardiovascular Diseases*/chemically induced
Humans ; Receptor, ErbB-2 ; Retrospective Studies ; Chemotherapy, Adjuvant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Autorzy:
Tsukamoto S; Department of Orthopaedic Surgery, Nara Medical University, 840, Shijo-cho, Kashihara 634-8521, Japan.
Mavrogenis AF; First Department of Orthopaedics, School of Medicine, National and Kapodistrian University of Athens, 41 Ventouri Street, Holargos, 15562 Athens, Greece.
Nitta Y; Department of Diagnostic Pathology, Nara Medical University, 840, Shijo-cho, Kashihara 634-8521, Japan.
Righi A; Department of Pathology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Rizzoli Orthopaedic Institute, Via di Barbiano 1/10, 40136 Bologna, Italy.
Masunaga T; Department of Orthopaedic Surgery, Nara Medical University, 840, Shijo-cho, Kashihara 634-8521, Japan.
Honoki K; Department of Orthopaedic Surgery, Nara Medical University, 840, Shijo-cho, Kashihara 634-8521, Japan.
Fujii H; Department of Orthopaedic Surgery, Nara Medical University, 840, Shijo-cho, Kashihara 634-8521, Japan.
Kido A; Department of Rehabilitation Medicine, Nara Medical University, 840, Shijo-cho, Kashihara 634-8521, Japan.
Tanaka Y; Department of Rehabilitation Medicine, Wakayama Professional University of Rehabilitation, 3-1, Minamoto-cho, Wakayama 640-8222, Japan.
Tanaka Y; Department of Orthopaedic Surgery, Nara Medical University, 840, Shijo-cho, Kashihara 634-8521, Japan.
Errani C; Department of Orthopaedic Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Rizzoli Orthopaedic Institute, Via Pupilli 1, 40136 Bologna, Italy.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jan 19; Vol. 31 (1), pp. 566-578. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Chondrosarcoma*/drug therapy
Sarcoma*/drug therapy
Bone Neoplasms*/drug therapy
Bone Neoplasms*/surgery
Humans ; Retrospective Studies ; Prospective Studies ; Chemotherapy, Adjuvant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Chemotherapy is of prognostic significance to metaplastic breast cancer.
Autorzy:
Zhang M; Department of breast surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, China.
Yuan J; Department of breast surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, China.
Wang M; Department of breast surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, China.
Zhang M; Department of breast surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, China.
Chen H; Department of breast surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 12; Vol. 14 (1), pp. 1210. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/pathology
Female ; Humans ; Prognosis ; Treatment Outcome ; Kaplan-Meier Estimate ; Retrospective Studies ; Chemotherapy, Adjuvant/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer.
Autorzy:
Conces ML; University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.
Mahipal A; University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jan 10; Vol. 31 (1), pp. 366-382. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasms, Second Primary*
Rectal Neoplasms*/drug therapy
Humans ; Neoadjuvant Therapy ; Chemoradiotherapy ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Pathologic Complete Response
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combining pathological risk factors and T, N staging to optimize the assessment for risk stratification and prognostication in low-risk stage III colon cancer.
Autorzy:
Xian ZY; Department of Colorectal Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Song YW; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Department of Radiotherapy, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Zhang ZJ; Department of Colorectal Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Gan YG; Department of Colorectal Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Chen YL; Department of Colorectal Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Hu T; Department of Colorectal Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Wen XF; Department of Colorectal Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Mo TW; Department of General Surgery, The First Affiliated Hospital of Jinan University, Jinan University, 613 West Huangpu Avenue, Guangzhou, 510630, Tianhe District, China. .; Department of General Surgery, Guangzhou First People's Hospital, No. 1 Panfu Road, Guangzhou, 510180, Yuexiu District, China. .
He XW; Department of Colorectal Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. .; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. .; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2024 Jan 04; Vol. 22 (1), pp. 10. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Colonic Neoplasms*/pathology
Humans ; Neoplasm Staging ; Prognosis ; Risk Factors ; Chemotherapy, Adjuvant ; Risk Assessment ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC.
Autorzy:
Shen ZQ; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China.
Feng KP; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China.
Fang ZY; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China.
Xia T; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China.
Pan S; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China.
Ding C; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China.
Xu C; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China.
Ju S; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China.
Chen J; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China.
Li C; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China. .
Zhao J; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, Suzhou, 215000, China. .
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Jan 02; Vol. 19 (1), pp. 1. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/drug therapy
Lung Neoplasms*/surgery
Humans ; Retrospective Studies ; Neoplasm Staging ; Chemotherapy, Adjuvant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study : Mohammed VI University Hospital, Medical Oncology Department, Marrakech, Morocco.
Autorzy:
Choulli F; Medical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco. .; Academic Health Observatory, Biosciences and Health Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco. .
Tafenzi HA; Medical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.; Academic Health Observatory, Biosciences and Health Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco.
Hattimy FE; Genetics and Biometry Department, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco.
Choulli MK; Academic Health Observatory, Biosciences and Health Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco.
Belbaraka R; Medical Oncology Department, Mohammed VI University Hospital of Marrakech, Marrakech, Morocco.; Academic Health Observatory, Biosciences and Health Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 17. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/etiology
Humans ; Female ; Middle Aged ; Anthracyclines/adverse effects ; Morocco/epidemiology ; Taxoids/adverse effects ; Chemotherapy, Adjuvant ; Medical Oncology ; Hospitals ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Value of adjuvant chemotherapy for patients with pT2N0M0 non-small cell lung cancer receiving radical resection.
Autorzy:
Chen S; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Yang S; School of Life Sciences, Fudan University, Shanghai, China.
Zhao Y; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang Y; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Huang Q; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Wu H; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Hu H; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Sun Y; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang Y; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Xiang J; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Ye T; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Chen H; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.; Institute of Thoracic Oncology, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Jan; Vol. 15 (3), pp. 258-265. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/drug therapy
Lung Neoplasms*/surgery
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/pathology
Humans ; Male ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Neoplasm Invasiveness/pathology ; Chemotherapy, Adjuvant
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes.
Autorzy:
Li X; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Li Z; Department of Clinical Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.
Li L; Depatment of Thyroid and Breast Surgery, Ningbo Medical Center, Li Huili Hospital, Ningbo, China.
Liu T; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Qian C; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Ren Y; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Li Z; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Chen K; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Ji D; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Zhang M; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Wang J; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 134-142. Date of Electronic Publication: 2023 Aug 14.
Typ publikacji:
Journal Article
MeSH Terms:
Tamoxifen*/therapeutic use
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Humans ; Female ; Toremifene/therapeutic use ; Cytochrome P-450 CYP2D6/genetics ; Cytochrome P-450 CYP2D6/therapeutic use ; Antineoplastic Agents, Hormonal/therapeutic use ; Chemotherapy, Adjuvant ; Genotype
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Changes in Invasive Breast Carcinomas after Neoadjuvant Chemotherapy Can Influence Adjuvant Therapeutic Decisions.
Autorzy:
Jaime Dos Santos B; Laboratory of Mammary Pathology, Department of Anatomical Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Balabram D; Department of Surgery, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Mara Reis Gomes V; Laboratory of Mammary Pathology, Department of Anatomical Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Costa Café de Castro C; Laboratory of Mammary Pathology, Department of Anatomical Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Henrique Costa Diniz P; Department of Medical Clinic, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Araújo Buzelin M; Institute of Teaching and Research of Santa Casa de Belo Horizonte, Belo Horizonte, Brazil.
Buzelin Nunes C; Laboratory of Mammary Pathology, Department of Anatomical Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 178-190. Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:
Journal Article
MeSH Terms:
Neoadjuvant Therapy*
Breast Neoplasms*/pathology
Humans ; Female ; Ki-67 Antigen ; Receptor, ErbB-2/metabolism ; Neoplasm Grading ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Intracavitary Chemotherapy after kidney-Sparing Therapy for Upper Tract Urothelial Carcinoma: A Meta-Analysis.
Autorzy:
Zhou H; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Pan Y; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Xu M; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Wang S; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Li Y; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Liu X; Department of Urology, General Hospital of Tianjin Medical University, Tianjin, 300052, China. .
Pokaż więcej
Źródło:
Urology journal [Urol J] 2023 Dec 26; Vol. 20 (6), pp. 369-378. Date of Electronic Publication: 2023 Dec 26.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/drug therapy
Kidney Neoplasms*/pathology
Ureteral Neoplasms*/drug therapy
Ureteral Neoplasms*/pathology
Humans ; Chemotherapy, Adjuvant ; Kidney/pathology ; Mitomycin/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Pre-operative clonal hematopoiesis is related to adverse outcome in lung cancer after adjuvant therapy.
Autorzy:
Yun JK; Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Ulsan University College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Republic of Korea.
Kim S; Genome Opinion Inc., Sungsu SKV1 Center, 1-721, 48, Achasan-Ro 17-Gil, Seongdong-Gu, Seoul, Republic of Korea.
An H; Genome Opinion Inc., Sungsu SKV1 Center, 1-721, 48, Achasan-Ro 17-Gil, Seongdong-Gu, Seoul, Republic of Korea.
Lee GD; Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Ulsan University College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Republic of Korea.
Kim HR; Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Ulsan University College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Republic of Korea.
Kim YH; Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Ulsan University College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Republic of Korea.
Kim DK; Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Ulsan University College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Republic of Korea.
Park SI; Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Ulsan University College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Republic of Korea.
Choi S; Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Ulsan University College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Republic of Korea. .
Koh Y; Genome Opinion Inc., Sungsu SKV1 Center, 1-721, 48, Achasan-Ro 17-Gil, Seongdong-Gu, Seoul, Republic of Korea. .; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101, Daehak-Ro, Jongno-Gu, Seoul, Republic of Korea. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2023 Dec 12; Vol. 15 (1), pp. 111. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Carcinoma, Non-Small-Cell Lung*/therapy
Carcinoma, Non-Small-Cell Lung*/drug therapy
Humans ; Clonal Hematopoiesis ; Chemotherapy, Adjuvant/methods ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Diagnosis and treatment of breast cancer in Denmark during the COVID-19 pandemic: a nationwide population-based study.
Autorzy:
Ibfelt EH; The Danish Clinical Quality Program - National Clinical Registries (RKKP), Copenhagen, Denmark.
Jensen H; The Danish Clinical Quality Program - National Clinical Registries (RKKP), Copenhagen, Denmark.
Vrou Offersen B; Department of Experimental Clinical Oncology, Aarhus University Hospital - Aarhus University, Aarhus, Denmark.
Bang Hansen M; The Danish Clinical Quality Program - National Clinical Registries (RKKP), Copenhagen, Denmark.; Palliative Care Research Department, Bispebjerg Hospital, Kobenhavn, Denmark.
Møller H; The Danish Clinical Quality Program - National Clinical Registries (RKKP), Copenhagen, Denmark.; Danish Centre for Health Service Research, Aalborg University, Aalborg, Denmark.
Christiansen P; Department of Plastic and Breast Surgery, Aarhus University Hospital, Aarhus, Denmark.; Danish Breast Cancer Cooperative Group - DBCG, Denmark.
Bech Olesen T; The Danish Clinical Quality Program - National Clinical Registries (RKKP), Copenhagen, Denmark.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1749-1756. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnosis
Breast Neoplasms*/epidemiology
Breast Neoplasms*/therapy
COVID-19*/epidemiology
Humans ; Female ; Adolescent ; Adult ; Middle Aged ; Aged ; Pandemics ; Chemotherapy, Adjuvant ; Denmark/epidemiology ; COVID-19 Testing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis.
Autorzy:
Ling Q; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Huang ST; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Yu TH; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Liu HL; West China School of Medicine, Sichuan University, Chengdu, China.
Zhao LY; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Chen XL; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Liu K; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Chen XZ; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Yang K; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China.; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Hu JK; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China. .; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. .
Zhang WH; Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China. .; Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2023 Dec 01; Vol. 21 (1), pp. 377. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/surgery
Humans ; Neoadjuvant Therapy/methods ; Retrospective Studies ; Disease-Free Survival ; Chemotherapy, Adjuvant/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cumulative incidence of first recurrence after curative treatment of stage I-III colorectal cancer. Competing risk analyses of temporal and anatomic patterns.
Autorzy:
Storli PE; Department of Gastrointestinal Surgery, Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Dille-Amdam RG; Department of Gastrointestinal Surgery, Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Skjærseth GH; Department of Gastrointestinal Surgery, Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Gran MV; Department of Gastrointestinal Surgery, Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Myklebust TÅ; Department of Registration, Cancer Registry of Norway, Oslo, Norway.; Department of Research, Møre and Romsdal Hospital Trust, Ålesund, Norway.
Grønbech JE; Department of Gastrointestinal Surgery, Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Bringeland EA; Department of Gastrointestinal Surgery, Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1822-1830. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/therapy
Colorectal Neoplasms*/drug therapy
Rectal Neoplasms*/pathology
Colonic Neoplasms*/drug therapy
Humans ; Incidence ; Chemotherapy, Adjuvant ; Risk Assessment ; Neoplasm Recurrence, Local/therapy ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Staging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adjuvant chemotherapy combined with immunotherapy in patients with cholangiocarcinoma after radical resection.
Autorzy:
Li XH; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhou EL; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhao CY; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Army Medical University, Chongqing, China.
Cui BK; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Dong XY; Department of Gynecology, Guangdong Hydropower Hospital, Guangzhou, China.
Du H; Reproductive and Genetic Medicine Center, Dalian Women and Children's Medical Group, Dalian, China.
Lin XJ; Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 21742-21750. Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Cholangiocarcinoma*/drug therapy
Cholangiocarcinoma*/pathology
Bile Duct Neoplasms*/pathology
Humans ; Lymphatic Metastasis ; Retrospective Studies ; Neoplasm Recurrence, Local/drug therapy ; Chemotherapy, Adjuvant ; Bile Ducts, Intrahepatic/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 21-40 z 4146

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies